| EURopean trial On reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators: Efficacy of perindopril in reduction of cardiovascular events … KM Fox Lancet 362, 782-788, 2003 | 346 | 2003 |
| Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) AJ Vallejo-Vaz, CAT Stevens, ARM Lyons, KI Dharmayat, T Freiberger, ... The Lancet 398 (10312), 1713-1725, 2021 | 203 | 2021 |
| EarLy Elimination of Fatty Acids iN hypertriglyceridemia-induced acuTe pancreatitis (ELEFANT trial): Protocol of an open-label, multicenter, adaptive randomized clinical trial N Zádori, N Gede, J Antal, A Szentesi, H Alizadeh, Á Vincze, F Izbéki, ... Pancreatology 20 (3), 369-376, 2020 | 49 | 2020 |
| Attaining United States and European guideline LDL-cholesterol levels with simvastatin in patients with coronary heart disease (the GOALLS study) F Garmendia, AS Brown, I Reiber, PC Adams Current medical research and opinion 16 (3), 208-219, 2000 | 39 | 2000 |
| Frequency of the R3500Q mutation of the apolipoprotein B-100 gene in a sample screened clinically for familial hypercholesterolemia in Hungary Á Kalina, A Császár, AE Czeizel, L Romics, F Szabóki, C Szalai, I Reiber, ... Atherosclerosis 154 (1), 247-251, 2001 | 37 | 2001 |
| Non-HDL cholesterol goal attainment and its relationship with triglyceride concentrations among diabetic subjects with cardiovascular disease: a nationwide survey of 2674 … L Mark, AJ Vallejo-Vaz, I Reiber, G Paragh, SRK Seshasai, KK Ray Atherosclerosis 241 (1), 62-68, 2015 | 33 | 2015 |
| Association of plasma lipid levels with apolipoprotein E polymorphism in Type 2 diabetes Á Kalina, C Szalai, Z Prohászka, I Reiber, A Császár Diabetes research and clinical practice 56 (1), 63-68, 2002 | 33 | 2002 |
| Persistence with statin therapy in Hungary Z Kiss, L Nagy, I Reiber, G Paragh, MP Molnar, G Rokszin, Z Abonyi-Toth, ... Archives of Medical Science 9 (3), 409-417, 2013 | 31 | 2013 |
| Effects of anacetrapib on plasma lipids in specific patient subgroups in the DEFINE (Determining the Efficacy and Tolerability of CETP INhibition with AnacEtrapib) trial EA Brinton, U Kher, S Shah, CP Cannon, M Davidson, AM Gotto, ... Journal of clinical lipidology 9 (1), 65-71, 2015 | 30 | 2015 |
| Postprandial triglyceride levels in familial combined hyperlipidemia. The role of apolipoprotein E and lipoprotein lipase polymorphisms I Reiber, I Mezõ, Á Kalina, G Pálos, L Romics, A Császár The Journal of Nutritional Biochemistry 14 (7), 394-400, 2003 | 26 | 2003 |
| Changes in attainment of lipid goals by general practitioners and specialists in patients at high cardiovascular risk in Hungary during 2004-2008 L Mark, G Paragh, I Karadi, I Reiber, G Pados Archives of Medical Science 6 (5), 695-700, 2010 | 22 | 2010 |
| How can we further improve the LDL-cholesterol target level achievement rate based on the Hungarian MULTI GAP 2011 study results and considering the new European dyslipidemia … L Mark, G Paragh, I Karadi, I Reiber, G Pados, Z Kiss Archives of Medical Science 8 (4), 608-613, 2012 | 16 | 2012 |
| An attempt to make lipid-lowering therapy more effective in Hungary. The results of MULTI GAP 2010 and the PLUS Program L Mark, G Paragh, I Karadi, I Reiber, G Pados, Z Kiss Archives of Medical Science 7 (5), 760-765, 2011 | 14 | 2011 |
| Evaluation of lipoprotein (a) in the prevention and management of atherosclerotic cardiovascular disease: a survey among the Lipid Clinics Network AL Catapano, L Tokgözoğlu, M Banach, M Gazzotti, E Olmastroni, ... Atherosclerosis 370, 5-11, 2023 | 13 | 2023 |
| Comparison of low-density lipoprotein cholesterol level calculated using the modified Martin/Hopkins estimation or the Friedewald formula with direct homogeneous assay measured … I Reiber, L Mark, G Paragh, PP Toth Archives of Medical Science: AMS 18 (3), 577, 2022 | 12 | 2022 |
| The role of ezetimibe in LDL cholesterol goal attainment in very high risk patients: the rosuvastatin monotherapy looks to be insufficient L Mark, G Paragh, I Reiber Current medical research and opinion 27 (10), 1959-1960, 2011 | 7 | 2011 |
| The good, the bad, and the atherogenic I Reiber, I Mezo, L Mark, G Paragh Journal of the American College of Cardiology 59 (14), 1333-1334, 2012 | 6 | 2012 |
| Egyre „célratörőbb” lipidterápiás szokásaink–A Magyar MULTI GAP 2010 eredményei= Becoming more focused therapeutic lipid patterns: results from the Hungarian MULTI GAP 2010 I Reiber, G Paragh, L Márk, G Pados Orvosi Hetilap 152 (21), 822-827, 2011 | 6 | 2011 |
| The effect of switching to the high-efficient rosuvastatin on the success of lipid lowering therapy in high risk patients L Mark, I Reiber, L Bajnok, I Karadi, G Paragh The CORVUS (Controlled Targets for High Vascular Risk Patients Using …, 2012 | 5 | 2012 |
| Az igazán atherogen koleszterin I Reiber, G Paragh, L Márk, G Pados, I Karádi | 5 | 2011 |
